Amniotic Fluid Embolism - Podcast Version TeachMeObGyn 0:00 / 0:00 1x 0.25x 0.5x 0.75x 1x 1.25x 1.5x 1.75x 2x Amniotic fluid embolism (AFE) is a recognised, yet rare cause of maternal collapse. It is often a fatal complication of pregnancy and the puerperium, and is a direct cause of maternal death. The most up to date UK data states that there is an incidence of 2/100,000 pregnancies. The cause of this phenomenon is still under debate however possible roles have been attributed to strong uterine contractions, excessive amniotic fluid and disruption of vessels supplying the uterus. It therefore remains a condition that is neither predictable nor preventable, with no established accurate premortem diagnostic test or investigation. Risk Factors As there is currently no consensus on a pathophysiological process, the risk factors for amniotic fluid embolism are based mostly on abnormalities of the amniotic fluid, uterus and placenta themselves. Common risk factors that occur in many complications of pregnancy also feature: By HBR (Own work) [CC BY-SA 3.0)], via Wikimedia Commons Fig 1Caesarean section is a risk factor for amniotic fluid embolism. Multiple pregnancy Increasing maternal age Induction of labour Uterine rupture Placenta praevia Placental abruption Cervical laceration Eclampsia Polyhydramnios Caesarean or instrumental delivery Clinical Features The physiology related to amniotic fluid embolism has been described as similar to anaphylaxis or severe sepsis. As such, the manifestations of this complication of pregnancy resemble these disease processes. It is characterised as an acute condition with the sudden onset of: Hypoxia/respiratory arrest Hypotension Fetal distress Seizures Shock Confusion Cardiac arrest Disseminated intravascular coagulation (this may be the first sign in some cases however nearly all patients will go on to develop this within 4 hours) The differential diagnosis will include other conditions that present in this way – such as pulmonary embolism, anaphylaxis, sepsis, eclampsia and myocardial infarction. It is therefore difficult to confirm the diagnosis and the focus should therefore revolve around resuscitation and stabilisation of the patient. Investigations and Management The mainstay of management in amniotic fluid embolism is resuscitation. Investigations are similar to those undertaken during cardiac arrest and other emergency scenarios. Some may not be possible. Bloods – FBC, U&E, calcium and magnesium, clotting studies, ABG ECG (ischaemic changes) Chest x-ray (shows pulmonary oedema) Early involvement of the multidisciplinary team is important. If this condition is suspected, anaesthetics must be involved to arrange intensive care admission. All of this coordination should occur whilst rapid maternal resuscitation is administered. Basic ABCDE approach must not be forgotten, with high flow oxygen essential to minimise neurological compromise and fluids given as appropriate in order to counteract hypotension and haemodynamic instability. Anaesthetics will be involved with measuring pulmonary artery wedge pressures and they will be able to take blood to assist with the diagnosis (shows fetal elements in the aspirate). Disseminated intravascular coagulation should be managed with the involvement of haematologists. If the baby is not yet delivered and the patient is relatively stable, continuous fetal monitoring should be instigated with a view to imminent delivery. However should cardiac arrest or severe maternal compromise occur, perimortem section is indicated to facilitate CPR of the mother. Definitive diagnosis of amniotic fluid embolism is only definitively confirmed on post mortem and demonstrates fetal squamous cells along with debris in the pulmonary vasculature. By Yale Rosen [CC BY-SA 2.0], via Wikimedia Commons Fig 2Amniotic fluid embolism, with intravascular squamous cells present. Summary Amniotic fluid embolism is a rare yet often fatal complication of pregnancy and the puerperium. Little is known of the pathophysiology yet it resembles anaphylaxis/severe sepsis in presentation. Risk factors relate to abnormalities of the placenta, uterus and amniotic fluid. The focus of management is resuscitation of the mother by any means necessary and it is important to involve all members of the multidisciplinary team. Diagnosis can only be made definitively at post mortem examination. Frequent questions What is amniotic fluid embolism and why is it significant? Amniotic fluid embolism (AFE) is a rare but serious complication of pregnancy that can lead to maternal collapse and death. It occurs when amniotic fluid enters the maternal circulation, causing acute physiological responses similar to anaphylaxis or severe sepsis. What are the common risk factors associated with amniotic fluid embolism? Risk factors for amniotic fluid embolism include multiple pregnancies, advanced maternal age, induction of labour, uterine rupture, placenta praevia, placental abruption, cervical laceration, eclampsia, polyhydramnios, and delivery via Caesarean or instrumental methods. What are the clinical features of amniotic fluid embolism? Amniotic fluid embolism is characterised by sudden onset of symptoms such as hypoxia, hypotension, fetal distress, seizures, shock, confusion, and potentially cardiac arrest. Disseminated intravascular coagulation may also occur within four hours of onset. How is amniotic fluid embolism managed in a clinical setting? Management of amniotic fluid embolism focuses on rapid resuscitation of the mother, involving a multidisciplinary team. Key interventions include administering high-flow oxygen, fluid resuscitation, and monitoring, with potential for perimortem caesarean section if severe maternal compromise occurs. How is the diagnosis of amniotic fluid embolism confirmed? The definitive diagnosis of amniotic fluid embolism can only be made post mortem, where fetal squamous cells and debris are identified in the pulmonary vasculature. Pre-mortem diagnosis is challenging and often relies on clinical presentation and exclusion of other conditions. Rate This Article